Literature DB >> 6200730

Inhibition of oxygen-centered free radical formation by the stable prostacyclin-mimetic iloprost (ZK 36 374) in acute myocardial ischemia.

C Thiemermann, E Steinhagen-Thiessen, K Schrör.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6200730

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN： 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  8 in total

1.  Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart.

Authors:  D Bani; E Masini; M G Bello; M Bigazzi; T B Sacchi
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

2.  Prostacyclin and iloprost: equal efficiency in preserving high energy phosphates in the dog heart following coronary artery ligation.

Authors:  M Pissarek; H Goos; J Nöhring; J Graff; G Buller; I Beyerdörfer; H J Mest; K F Lindenau; E G Krause
Journal:  Basic Res Cardiol       Date:  1987 Nov-Dec       Impact factor: 17.165

3.  Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts.

Authors:  R Ferrari; A Cargnoni; S Curello; G M Boffa; C Ceconi
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

4.  Effects of iloprost, a PGI2 derivative, on ischemic myocardial energy and carbohydrate metabolism in dogs.

Authors:  K Ichihara; K Yamamoto; Y Abiko
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

5.  Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.

Authors:  M A Cotter; K C Dines; N E Cameron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

Review 6.  Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.

Authors:  S M Grant; K L Goa
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

7.  Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue.

Authors:  M Elias; A Heethuis; M Weggemans; V Bom; N Blom; R L McShine; M R Halie; C T Smit Sibinga
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

8.  Prolonged infusion of prostacyclin in patients with advanced stages of peripheral vascular disease: a placebo-controlled cross-over study.

Authors:  V Hossmann; H Auel; W Rücker; K Schrör
Journal:  Klin Wochenschr       Date:  1984-12-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.